Tech Company Financing Transactions

Attralus Funding Round

Attralus, operating out of San Francisco, secured $25 million in investment from venBio and private investors.

Transaction Overview

Company Name
Announced On
9/15/2020
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series A
Investors

venBio (Lead Investor) (Richard Gaster)

Proceeds Purpose
The Series A will allow Attralus to further validate their pan-amyloid imaging agent.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
329 Oyster Point Blvd. 3rd Floor
San Francisco, CA 94080
USA
Phone
Undisclosed
Email Address
Overview
Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients with systemic amyloidosis. Its proprietary peptide-based pan-amyloid targeting agents have the potential to diagnose and treat all forms and stages of systemic amyloidosis.
Profile
Attralus LinkedIn Company Profile
Social Media
Attralus Company Twitter Account
Company News
Attralus News
Facebook
Attralus on Facebook
YouTube
Attralus on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Mark Timney
  Mark Timney LinkedIn Profile  Mark Timney Twitter Account  Mark Timney News  Mark Timney on Facebook
Chief Financial Officer
Benson Fong
  Benson Fong LinkedIn Profile  Benson Fong Twitter Account  Benson Fong News  Benson Fong on Facebook
Chief Medical Officer
Gregory Bell
  Gregory Bell LinkedIn Profile  Gregory Bell Twitter Account  Gregory Bell News  Gregory Bell on Facebook
Chief Operating Officer
Spencer Guthrie
  Spencer Guthrie LinkedIn Profile  Spencer Guthrie Twitter Account  Spencer Guthrie News  Spencer Guthrie on Facebook
Chief Scientific Officer
Jonathan Wall
  Jonathan Wall LinkedIn Profile  Jonathan Wall Twitter Account  Jonathan Wall News  Jonathan Wall on Facebook
VP - Bus. Development
Glen Firestone
  Glen Firestone LinkedIn Profile  Glen Firestone Twitter Account  Glen Firestone News  Glen Firestone on Facebook
VP - Bus. Development
Krishna Gorti
  Krishna Gorti LinkedIn Profile  Krishna Gorti Twitter Account  Krishna Gorti News  Krishna Gorti on Facebook
VP - Human Resources
Christine Huh
  Christine Huh LinkedIn Profile  Christine Huh Twitter Account  Christine Huh News  Christine Huh on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/15/2020: Courier venture capital transaction
Next: 9/15/2020: Escient Pharmaceuticals venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to report on funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary